• Je něco špatně v tomto záznamu ?

A Review of Molecular and Genetic Diagnostics of Myeloid Malignancies with Emphasis on Diagnostics in Bosnia and Herzegovina

A. Kurtovic-Kozaric, E. Islamagic, A. Asic, L. Mehinovic-Cavcic, L. Besic, H. Sahinbegovic, H. Komic, S. Kurtovic, L. Burazerovic

. 2021 ; 50 (1) : 175-196. [pub] -

Jazyk angličtina Země Bosna a Hercegovina

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004471

Here we describe the major genetic and genomic aberrations found in myeloid malignancies and how those markers are used in patients' diagnosis, prognosis, and targeted treatment. In Bosnia and Herzegovina, cytogenetic and molecular diagnostics for myeloid malignancies have been established and continually improved since 2005. We report the current state of available diagnostic tools for myeloid malignancies in Bosnia and Herzegovina. Myeloid malignancies are a heterogeneous group of clonal blood diseases characterized by defects in hematopoietic stem cells and myeloid progenitors that lead to abnormal proliferation, differentiation, localization, and self-renewal. Most common myeloid malignancies include myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). Molecular diagnostics of myeloid malignancies have significantly expanded in the last decade with new genetic and genomic markers for diagnosis, prognosis, and treatment. CONCLUSION: In the last decade, several new genomic markers important for patient diagnosis, prognosis, and therapy have been discovered that need to be implemented in routine molecular diagnostics not only in developed nations but also in developing nations such as Bosnia and Herzegovina.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004471
003      
CZ-PrNML
005      
20220127145219.0
007      
ta
008      
220113s2021 bn f 000 0|eng||
009      
AR
024    7_
$a 10.5644/ama2006-124.334 $2 doi
035    __
$a (PubMed)34075772
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a bn
100    1_
$a Kurtovic-Kozaric, Amina $u Department of Clinical Pathology, Cytology and Human Genetics, Clinical Center of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina; Faculty of Science, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina. amina.kozaric@kcus.ba
245    12
$a A Review of Molecular and Genetic Diagnostics of Myeloid Malignancies with Emphasis on Diagnostics in Bosnia and Herzegovina / $c A. Kurtovic-Kozaric, E. Islamagic, A. Asic, L. Mehinovic-Cavcic, L. Besic, H. Sahinbegovic, H. Komic, S. Kurtovic, L. Burazerovic
520    9_
$a Here we describe the major genetic and genomic aberrations found in myeloid malignancies and how those markers are used in patients' diagnosis, prognosis, and targeted treatment. In Bosnia and Herzegovina, cytogenetic and molecular diagnostics for myeloid malignancies have been established and continually improved since 2005. We report the current state of available diagnostic tools for myeloid malignancies in Bosnia and Herzegovina. Myeloid malignancies are a heterogeneous group of clonal blood diseases characterized by defects in hematopoietic stem cells and myeloid progenitors that lead to abnormal proliferation, differentiation, localization, and self-renewal. Most common myeloid malignancies include myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). Molecular diagnostics of myeloid malignancies have significantly expanded in the last decade with new genetic and genomic markers for diagnosis, prognosis, and treatment. CONCLUSION: In the last decade, several new genomic markers important for patient diagnosis, prognosis, and therapy have been discovered that need to be implemented in routine molecular diagnostics not only in developed nations but also in developing nations such as Bosnia and Herzegovina.
650    _2
$a lidé $7 D006801
650    12
$a akutní myeloidní leukemie $x diagnóza $x genetika $7 D015470
650    12
$a myelodysplastické syndromy $x diagnóza $x genetika $7 D009190
650    12
$a myeloproliferativní poruchy $x diagnóza $x genetika $7 D009196
650    _2
$a prognóza $7 D011379
651    _2
$a Bosna a Hercegovina $7 D017522
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Islamagic, Erna $u Faculty of Science, University of Sarajevo, Sarajevo, Bosnia and Herzegovina
700    1_
$a Asic, Adna $u Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina
700    1_
$a Mehinovic-Cavcic, Lejla $u Faculty of Science, University of Sarajevo, Sarajevo, Bosnia and Herzegovina
700    1_
$a Besic, Larisa $u Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina
700    1_
$a Sahinbegovic, Hana $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic; Faculty of Science, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Komic, Hana $u TIMM Laboratory, Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
700    1_
$a Kurtovic, Sabira $u Hematology Clinic, Clinical Center of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina
700    1_
$a Burazerovic, Lejla $u Hematology Clinic, Clinical Center of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina
773    0_
$w MED00172292 $t Acta medica academica $x 1840-2879 $g Roč. 50, č. 1 (2021), s. 175-196
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34075772 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145215 $b ABA008
999    __
$a ok $b bmc $g 1751818 $s 1155620
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 50 $c 1 $d 175-196 $e - $i 1840-2879 $m Acta medica academica $n Acta Med Acad $x MED00172292
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace